The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients previously treated with at least one prior systemic therapy.
 
Amod Sarnaik
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - B4CC
Research Funding - Genentech (Inst); Iovance Biotherapeutics (Inst); Provectus (Inst)
Patents, Royalties, Other Intellectual Property - Compositions and methods for improving tumor-infiltrating lymphocytes for adoptive cell therapy, filed March 20, 2014 U.S. Patent Application No. 61/955,970 and second Application No. 61/973,002 (Inst)
 
Sajeve Samuel Thomas
No Relationships to Disclose
 
Diwakar Davar
Consulting or Advisory Role - Incyte; Merck
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Incyte; Incyte; Merck
 
John M. Kirkwood
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Immunocore; Novartis; Roche
Research Funding - Immunocore (Inst); Merck (Inst); Prometheus (Inst)
 
Harriet M. Kluger
Consulting or Advisory Role - Alexion Pharmaceuticals; Biodesix; Celldex; Corvus Pharmaceuticals; Genentech/Roche; Iovance Biotherapeutics; Nektar; Pfizer
Research Funding - Apexigen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Jose Lutzky
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Novartis
Research Funding - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Elios Pharmaceutical; Genentech/Roche; Incyte; Merck; Merck Serono; Novartis; Pfizer; Viralytics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Melissa Wilson
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb
 
Anna C. Pavlick
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Merck; Novartis; Regeneron; Sanofi/Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst); Millennium (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Regeneron; Sanofi/Regeneron
 
Brendan D. Curti
Consulting or Advisory Role - Alligator Bioscience; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune; Prometheus
 
Eric D. Whitman
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Castle Biosciences; Genentech/Roche; Merck Sharp & Dohme; Novartis
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Castle Biosciences; Genentech/Roche; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Dynavax Technologies (Inst); Genentech/Roche (Inst); Iovance Biotherapeutics (Inst); Merck Sharp & Dohme (Inst); Oncolys BioPharma (Inst); OncoSec (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Nerve monitoring dissection device; patent pending medical device which is a geometric surgical retractor
 
Giao Q. Phan
No Relationships to Disclose
 
Marc S. Ernstoff
Stock and Other Ownership Interests - GE Healthcare
Consulting or Advisory Role - Bristol-Myers Squibb; Celyad; EMD Serono; Lion Biotechnologies; Omniseq
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merrimack (Inst)
 
Kathryn Toshimi Takamura
Employment - Iovance Biotherapeutics
Stock and Other Ownership Interests - Iovance Biotherapeutics
Travel, Accommodations, Expenses - Iovance Biotherapeutics
 
Debora Barton
Employment - Advanced Accelerator Applications; Celgene; Iovance Biotherapeutics
Stock and Other Ownership Interests - Advanced Accelerator Applications; Celgene; Iovance Biotherapeutics
 
Sam Suzuki
Employment - Iovance Biotherapeutics
Stock and Other Ownership Interests - Acadia Pharmaceuticals; Auxilium; Iovance Biotherapeutics; Novocure; Omeros
Consulting or Advisory Role - Iovance Biotherapeutics
Travel, Accommodations, Expenses - Iovance Biotherapeutics
 
Lavakumar Karyampudi
Employment - Iovance Biotherapeutics
Stock and Other Ownership Interests - Iovance Biotherapeutics
Patents, Royalties, Other Intellectual Property - Iovance Biotherapeutics
Travel, Accommodations, Expenses - Iovance Biotherapeutics
 
Nancy Louise Samberg
Employment - Iovance Biotherapeutics
 
Maria Fardis
Employment - Acerta Pharma; Iovance Biotherapeutics
Leadership - Acerta Pharma; Iovance Biotherapeutics
Stock and Other Ownership Interests - Abbvie; Acerta Pharma; Gilead Sciences; Iovance Biotherapeutics
Patents, Royalties, Other Intellectual Property - Acerta Pharma (Inst); Iovance Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Acerta Pharma; Iovance Biotherapeutics
 
Jason Alan Chesney
Consulting or Advisory Role - Amgen; Iovance Biotherapeutics
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Iovance Biotherapeutics